SCHEMBL5589031

SCHEMBL5589031

CCCCOC(C)c1cccc(O)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.46
TYR P14679 1/20 0.46
ACHE P22303 1/20 0.46
TSHR P16473 2/20 0.41
IAPP P10997 2/20 0.38
ESR1 P03372 1/20 0.37
GABRA1 P14867 2/20 0.37
GABRB2 P47870 2/20 0.37
LMNA P02545 2/20 0.37
CYP3A4 P08684 2/20 0.37
HPGD P15428 2/20 0.37
FAAH O00519 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CYP1A2 P05177 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRG2 P18507 1/20 0.37
PTGS1 P23219 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587708 0.94 BCHE (0.43) BCHETYRACHEESR1CNR2
SCHEMBL5588721 0.94 BCHE (0.43) BCHETYRACHEESR1CNR2
SCHEMBL5589998 0.94 BCHE (0.43) BCHETYRACHEESR1CNR2
SCHEMBL25274542 0.87 TSHR (0.52) TSHRESR1GABRA1GABRB2LMNA
SCHEMBL5589798 0.85 BCHE (0.43) BCHETYRACHETSHRIAPP
SCHEMBL5587830 0.83 BCHE (0.44) BCHETYRACHETSHRIAPP
SCHEMBL5589017 0.81 BCHE (0.40) BCHETYRACHETSHRIAPP
SCHEMBL5589520 0.81 BCHE (0.40) BCHETYRACHETSHRIAPP
SCHEMBL5586900 0.80 SLC37A4 (0.44) BCHETYRACHETSHRIAPP
SCHEMBL5589041 0.80 KDM4E (0.39) TSHRESR1LMNACYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 BCHE 4508/4885TYR 1073/4885ACHE 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.